Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

Sarah L Tansley, Zoe E Betteridge, Harsha Gunawardena, Thomas S Jacques, Catherine M Owens, Clarissa Pilkington, Katie Arnold, Shireena Yasin, Elena Moraitis, Lucy R Wedderburn, Neil J McHugh

Research output: Contribution to journalArticle

78 Citations (Scopus)
39 Downloads (Pure)

Abstract

The aim of this study was to define the frequency and associated clinical phenotype of anti-MDA5 autoantibodies in a large UK based, predominantly Caucasian, cohort of patients with juvenile dermatomyositis (JDM).
Original languageEnglish
Article numberR138
Pages (from-to)1-8
Number of pages8
JournalArthritis Research & Therapy
Volume16
Issue number4
DOIs
Publication statusPublished - 2 Jul 2014

Fingerprint Dive into the research topics of 'Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study'. Together they form a unique fingerprint.

  • Cite this

    Tansley, S. L., Betteridge, Z. E., Gunawardena, H., Jacques, T. S., Owens, C. M., Pilkington, C., Arnold, K., Yasin, S., Moraitis, E., Wedderburn, L. R., & McHugh, N. J. (2014). Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Research & Therapy, 16(4), 1-8. [R138]. https://doi.org/10.1186/ar4600